Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Gomez-Zepeda, David; Michna, Thomas; Ziesmann, Tanja et al.
HowDirty: An R package to evaluate molecular contaminants in LC-MS experimentsPROTEOMICS. 2023
Tometten, Mareike; Kirschner, Martin; Meyer, Robert et al.
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified CriteriaHEMASPHERE. Bd. 7. H. 5. 2023
Gross, Catharina C.; Schulte-Mecklenbeck, Andreas; Steinberg, Olga V. et al.
Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectoriesNEUROLOGY. Bd. 100. H. 17. 2023
Volkmar, Michael; Fakhr, Elham; Zens, Stefan et al.
Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoiresFRONTIERS IN IMMUNOLOGY. Bd. 14. 2023
Bittner, Stefan; Zipp, Frauke
IL-17 receptor goes solo in autoimmune inflammationIMMUNITY. Bd. 56. H. 9. 2023 S. 1977-1980
Brabec, Tomas; Vobonl, Matous; Schierova, Dagmar et al.
IL-17-driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileumMUCOSAL IMMUNOLOGY. Bd. 16. H. 4. 2023 S. 373-385
Guedes, Joana R.; Ferreira, Pedro A.; Costa, Jessica et al.
IL-4 shapes microglia-dependent pruning of the cerebellum during postnatal developmentNEURON. Bd. 111. H. 21. 2023 S. 3435-3449
Lutz, Veronika; Hellmund, Veronique M.; Picard, Felix S. R. et al.
IL18 Receptor Signaling Regulates Tumor-Reactive CD8<SUP>+</SUP> T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer ModelCANCER IMMUNOLOGY RESEARCH. Bd. 11. H. 4. 2023 S. 421-434
Moos, S.; Mohebiany, A. N.; Waisman, A. et al.
Imiquimod-induced psoriasis-like dermatitis in mice depends on IL-17 signaling of keratinocytesEXPERIMENTAL DERMATOLOGY. Bd. 32. H. 4. 2023 S. E26-E26
Ziemssen, Tjalf; Schlegel, Eugen; Winkelmann, Veronika et al.
Immune response to SARS-CoV-2 mRNA booster vaccinations in relapsing multiple sclerosis patients treated with ofatumumab s.c. - Final results from the open-label multicenter KYRIOS trialMULTIPLE SCLEROSIS JOURNAL. Bd. 29. 2023 S. 361-362